- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Industry sectors - expenditure on research and development 2012-2016
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Industry sectors - expenditure on research and development 2012-2016
Percentage of spending on research and development of total revenue from 2012 to 2016, by industrial sector*
This statistic represents the percentage of expenditure on research and development of total revenue from 2012 to 2016, by industrial sector. The data were generated from the numbers of the 2,500 top companies worldwide. In 2016, spending on research and development accounted for about 2.9 percent of total revenue in the chemical industry.
Percentage of spending on research and development of total revenue from 2012 to 2016, by industrial sector*
| Industry sector | 2012 | 2014 | 2016 |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Industry sector | 2012 | 2014 | 2016 |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic represents the percentage of expenditure on research and development of total revenue from 2012 to 2016, by industrial sector. The data were generated from the numbers of the 2,500 top companies worldwide. In 2016, spending on research and development accounted for about 2.9 percent of total revenue in the chemical industry.
Show more- Show sources information
- Show publisher information
- Release date
- June 2018
- Region
- Worldwide
- Survey time period
- 2012 to 2016
- Supplementary notes
-
EFPIA stands for European Federation of Pharmaceutical Industries and Associations.
This statistic was assembled from several editions of this report.
* Data relate to the top 2,500 companies with registered offi ces in the EU (590), Japan (356), the US (837), China (327) and the Rest of the World (390), ranked by total worldwide R&D investment (with investment in R&D above € 21 million).
Source
- Show sources information
- Show publisher information
- Release date
- June 2018
More information
- Region
- Worldwide
- Survey time period
- 2012 to 2016
- Supplementary notes
-
EFPIA stands for European Federation of Pharmaceutical Industries and Associations.
This statistic was assembled from several editions of this report.
* Data relate to the top 2,500 companies with registered offi ces in the EU (590), Japan (356), the US (837), China (327) and the Rest of the World (390), ranked by total worldwide R&D investment (with investment in R&D above € 21 million).
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Clinical trials
- 92 page/s
- English
- pptx
- Detailed references
Everything On "Clinical trials" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Clinical trials"
- R&D overview
The most important statistics
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2010-2024
- Percentage of spending on research and development of total revenue from 2012 to 2016, by industrial sector*Industry sectors - expenditure on research and development 2012-2016
- Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2018 (in million U.S. dollars)Top pharmaceutical R&D projects based on net present value May 2018
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2017
- Pharmaceutical research and development spending in selected European countries in 2016 (in million euros)Research and development in European pharmaceutical industry by country 2016
- Total clinical research funding by the National Institutes for Health (NIH) from FY 2013 to FY 2019 (in million U.S. dollars)Total clinical research funding by National Institutes for Health 2013-2019
- Top R&D companies
The most important statistics
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
- World's top 50 pharmaceutical and biotechnology companies based on R&D spending growth in 2017/2018Top pharmaceutical companies in R&D spending growth 2017-2018
- Number of patients who took part in clinical trials for pharmaceutical company Roche from 2009 to 2017*Roche: participation of patients in clinical trials 2009-2017
- Top global contract research organizations (CROs) based on 2017 revenue (in million U.S. dollars)Leading global contract research organizations based on revenue 2017
- Clinical studies
The most important statistics
- Complexity of clinical trials compared in 2001-2005 and 2011-2015Comparison between the complexity of clinical trials 2001-2015
- Increase in clinical trials' complexity between 2001-2005 and 2011-2015Increase in clinical trials' complexity 2001-2015
- Number of registered clinical studies worldwide by location as of August 2018Number of registered clinical studies by location worldwide 2018
- Percentage of registered clinical studies worldwide by location as of August 2018Percent of registered clinical studies worldwide by location 2018
- Percentage of registered recruiting clinical studies worldwide by location as of August 2018Share of recruiting clinical studies worldwide by location 2018
- Total number of registered clinical studies worldwide since 2000 (as of August 2018)*Total number of registered clinical studies worldwide since 2000
- Total number of registered clinical studies with posted results worldwide since 2009 (as of August 2018)*Total number of registered clinical studies with posted results worldwide 2009-2018
- Participation
The most important statistics
- Percentage of population enrolled in clinical trials in selected countries worldwide as of 2016Clinical trial enrollment by select country and region 2016
- Top 20 countries by number of clinical trial participants in 2015-2016Top clinical trial participant countries 2015-2016, by number
- Top 20 clinical trial participant countries worldwide in 2015-2016, by share of participants (in percentage)Top clinical trial participant countries worldwide 2015-16, by share
- Number of clinical trial participants in the U.S. and rest of the world in 2016, by therapeutic areaClinical trial participants U.S. vs. rest of world by therapy area 2016
- Gender share of clinical trial participants worldwide in 2015-2016, by geographic locationClinical trial participants gender share worldwide 2015-16, by geographic location
- Ethnicity share of clinical trial participants worldwide in 2015-2016, by geographic location (in percentage)Clinical trial participants ethnicity share worldwide 2015-16, by geographic location
- Costs and market
The most important statistics
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
- Total R&D costs for selected cancer drugs on the market as of 2017 (in million U.S. dollars)Total R&D costs of select cancer drugs 2017
- Market share of clinical trials worldwide by segment as of 2016Market share of clinical trials worldwide by segment
- Clinical contract research organization (CRO) market worldwide from 2011 to 2020 (in billion U.S. dollars)Clinical CRO market size worldwide 2011-2020
- Size of the U.S. market for healthcare contract research outsourcing (CRO) from 2016 to 2022, by type (in million U.S. dollars)Size of U.S. healthcare CRO market 2016-2022 by type
- Size of the total U.S. clinical trial supplies market from 2016 to 2025 (in million U.S. dollars)Size of total U.S. clinical trial supplies market 2016-2025
- Success rates
The most important statistics
- Probability of success for drugs in the U.S. in different development phases between 2006 and 2015U.S. drug development phase success rates 2006-2015
- Probability of Phase II success for new drugs in select disease areas in the U.S. between 2006 and 2015U.S. drug development Phase II success rates 2006-2015, by disease area
- The probability of Phase III success for new drugs in select disease areas in the U.S. between 2006 and 2015U.S. drug development Phase III success rates from 2006 to 2015, by disease area
- Probability of success for oncology vs non-oncology drugs in the U.S. in the different development phases from 2006 to 2015U.S. development Phase success rates for oncology and non oncology drugs 2006-2015
- Probability of success for new drugs in the U.S. by development phase between 2006 and 2015, by drug classification U.S. drug development Phase success rates, by drug classification 2006-2015
- Probability of success for new drugs in the U.S. with and without selection biomarkers by development phase between 2006 and 2015U.S. development phase success rates for drugs with and without biomarkers 2006-2015
- Approvals, launches, setbacks
The most important statistics
- Number of new chemical or biological entities developed between 1992 and 2017, by region of originPharmaceutical industry - number of new substances 1992-2017
- Total number of novel drugs approved by CDER from 2008 to 2018Number of novel drugs approved annually by CDER 2008-2018
- Percentage of drugs approved by the U.S. Center for Drug Evaluation and Research (CDER) in 2018 that met select key measurementsKey measurements of U.S. CDER drug approvals in 2018
- Number of first premarket approvals (PMA/HDE) granted by the FDA for medtech products from 2005 to 2018FDA first premarket approvals for medtech products granted 2005-2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Number of unsuccessful Alzheimer’s drugs in development in the U.S. from 1998 to 2017Number of unsuccessful Alzheimer’s drugs in development in the U.S. 1998-2017
- Unsuccessful attempts and new drugs for select cancer types between 1998 and 2014Unsuccessful attempts and new drugs for cancer types 1998-2014
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Pharmaceutical industry: the cost of introducing a new product 1979-2012
- Annual compensation in U.S. biopharmaceutical industry vs. national average 2015
- Total revenue of the French drug market worldwide 2010-2014
- Alimentary tract and metabolism pharmaceutical consumption in Slovenia 2006-2016
- Hypnotics and sedatives pharmaceutical consumption in Spain 2004-2014
- Analgesics pharmaceutical consumption in Spain 2004-2014
- Value of exported pharmaceutical drugs from Japan to Asia 2011-2016
- Most prescribed subsidized prescription drugs by nurse practitioners Australia 2015
- U.S. adults impression of the U.S. pharma companies labor conditions
- Alimentary tract and metabolism pharmaceutical consumption in Greece 2000-2004
- Biopharmaceutical industry employment total impact U.S. 2009 and 2015
- Number of non-subsidized prescriptions by ATC group in Australia 2015
- Share of global pharmaceutical industry by gross value added by region 2014
- Global pharmaceutical industry by gross value added 2006-2014
- Pharmaceutical industry - sales growth by therapeutic classes
- Domestic pharmaceutical goods/medical device domestic sales in Japan FY 2016, by type
- Personnel costs of the manufacture of pharmaceutical products in Slovakia 2008-2016
- Chile: pharmaceutical product exports by value 2013-2017
- Drug production value share of digestive organ agents Japan 2016, by category
- Net sales change rate of Indian pharma industry in 2017-2019
Studies
- Pharmaceutical industry in Italy
- Pharmaceutical industry in Japan
- Pharmaceutical industry in China
- Pharmaceutical industry in the Netherlands
- Biotechnology Industry in Europe
- Vaccine industry in China
- Pharmaceutical trends in Europe
- 2018 PhRMA Annual Membership Survey
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
- Unleashing Pharma from the R&D Value Chain
- Putting the Science back into Life Sciences
- Indicatori Farmaceutici
- Generic Pharmaceutical Industry Yearbook 2016
- Life Sciences Outlook United States 2017
- Global Participation in Clinical Trials Report 2015-2016
Statistics on "Clinical trials"
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)
- Percentage of spending on research and development of total revenue from 2012 to 2016, by industrial sector*
- Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2018 (in million U.S. dollars)
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*
- Pharmaceutical research and development spending in selected European countries in 2016 (in million euros)
- Total clinical research funding by the National Institutes for Health (NIH) from FY 2013 to FY 2019 (in million U.S. dollars)
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*
- World's top 50 pharmaceutical and biotechnology companies based on R&D spending growth in 2017/2018
- Number of patients who took part in clinical trials for pharmaceutical company Roche from 2009 to 2017*
- Top global contract research organizations (CROs) based on 2017 revenue (in million U.S. dollars)
- Complexity of clinical trials compared in 2001-2005 and 2011-2015
- Increase in clinical trials' complexity between 2001-2005 and 2011-2015
- Number of registered clinical studies worldwide by location as of August 2018
- Percentage of registered clinical studies worldwide by location as of August 2018
- Percentage of registered recruiting clinical studies worldwide by location as of August 2018
- Total number of registered clinical studies worldwide since 2000 (as of August 2018)*
- Total number of registered clinical studies with posted results worldwide since 2009 (as of August 2018)*
- Percentage of population enrolled in clinical trials in selected countries worldwide as of 2016
- Top 20 countries by number of clinical trial participants in 2015-2016
- Top 20 clinical trial participant countries worldwide in 2015-2016, by share of participants (in percentage)
- Number of clinical trial participants in the U.S. and rest of the world in 2016, by therapeutic area
- Gender share of clinical trial participants worldwide in 2015-2016, by geographic location
- Ethnicity share of clinical trial participants worldwide in 2015-2016, by geographic location (in percentage)
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*
- Total R&D costs for selected cancer drugs on the market as of 2017 (in million U.S. dollars)
- Market share of clinical trials worldwide by segment as of 2016
- Clinical contract research organization (CRO) market worldwide from 2011 to 2020 (in billion U.S. dollars)
- Size of the U.S. market for healthcare contract research outsourcing (CRO) from 2016 to 2022, by type (in million U.S. dollars)
- Size of the total U.S. clinical trial supplies market from 2016 to 2025 (in million U.S. dollars)
- Probability of success for drugs in the U.S. in different development phases between 2006 and 2015
- Probability of Phase II success for new drugs in select disease areas in the U.S. between 2006 and 2015
- The probability of Phase III success for new drugs in select disease areas in the U.S. between 2006 and 2015
- Probability of success for oncology vs non-oncology drugs in the U.S. in the different development phases from 2006 to 2015
- Probability of success for new drugs in the U.S. by development phase between 2006 and 2015, by drug classification
- Probability of success for new drugs in the U.S. with and without selection biomarkers by development phase between 2006 and 2015
- Number of new chemical or biological entities developed between 1992 and 2017, by region of origin
- Total number of novel drugs approved by CDER from 2008 to 2018
- Percentage of drugs approved by the U.S. Center for Drug Evaluation and Research (CDER) in 2018 that met select key measurements
- Number of first premarket approvals (PMA/HDE) granted by the FDA for medtech products from 2005 to 2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
- Number of unsuccessful Alzheimer’s drugs in development in the U.S. from 1998 to 2017
- Unsuccessful attempts and new drugs for select cancer types between 1998 and 2014
- Estimated costs for the introduction of a new chemical or biological pharmaceutical product from 1979 to 2012 (in million U.S. dollars)
- Average annual compensation in the U.S. biopharmaceutical industry vs. national average in 2015 (in U.S. dollars)*
- Total revenue of the French drug market worldwide from 2010 to 2014, in maker pre-tax price* (in million euros)
- Consumption of alimentary tract and metabolism pharmaceuticals per 1,000 inhabitants per day* in Slovenia from 2006 to 2016
- Consumption of hypnotics and sedatives per 1,000 inhabitants per day in Spain from 2004 to 2014
- Consumption of analgesics per 1,000 inhabitants per day in Spain from 2004 to 2014
- Value of Japanese pharmaceutical drug exports to Asia from 2011 to 2016 (in billion Japanese yen)
- Leading subsidized prescription drugs that are most often prescribed by nurse practitioners in Australia in 2015
- How would you rate the U.S. pharma industry concerning the labor conditions in the companies?
- Consumption of alimentary tract and metabolism pharmaceuticals per 1,000 inhabitants per day* in Greece from 2000 to 2004
- Employment in the U.S. biopharmaceutical industry and national impact in 2009 vs. 2015
- Breakdown of the number of under co-payment prescriptions in Australia in 2015, by ATC group (in millions)
- Distribution of gross value added in the global pharmaceutical industry in 2014, by region*
- Gross value added in the global pharmaceutical industry from 2006 to 2014 (in billion U.S. dollars)
- Sales growth of selected pharmaceutical major therapeutic classes in 2010
- Domestic sales value of domestically produced medical devices and pharmaceutical goods in Japan in fiscal year 2016, by product type (in billion Japanese yen)
- Personnel costs of the manufacture of basic pharmaceutical products and pharmaceutical preparations in Slovakia from 2008 to 2016 (in million euros)
- Value of pharmaceutical product exports from Chile from 2013 to 2017 (in 1,000 U.S. dollars)
- Distribution of the drug production value of digestive organ agents in Japan in 2016, by sub therapeutic category
- Net sales change rate of Indian pharma industry from H1 2017 to H1 2019
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.